Nyxoah Archives | Page 7 of 15 | Be Korea-savvy
Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer

Nyxoah Appoints Christoph Eigenmann as Chief Commercial Officer

Mont-Saint-Guibert, Belgium, May 10 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Christoph Eigenmann as Chief Commercial Officer. Christoph will oversee commercial activities globally, be responsible for sales and marketing in existing [...]

Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023

Nyxoah to Release First Quarter 2023 Financial Results on May 16, 2023

Mont-Saint-Guibert, Belgium, May 1 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the first quarter of 2023 on Tuesday, May  16, 2023, after market close. Company management [...]

Publication Relating to Transparency Notifications

Publication Relating to Transparency Notifications

Mont-Saint-Guibert (Belgium), April 20 (Korea Bizwire) – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below. Together Partnership On April 18, 2023, Nyxoah received a transparency notification from Together Partnership following the crossing of the 10% [...]

Information on the Total Number of Voting Rights and Shares

Information on the Total Number of Voting Rights and Shares

Mont-Saint-Guibert (Belgium), April 17 (Korea Bizwire) – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.  Share capital: EUR 4,923,807.45  Total number of securities carrying voting rights: 28,661,985 (all ordinary shares)   Total number of voting rights (= denominator): 28,661,985 (all [...]

Nyxoah Raises $3 Million from its At-the-Market Equity Offering

Nyxoah Raises $3 Million from its At-the-Market Equity Offering

Mont-Saint-Guibert, Belgium, April 13 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company raised $3.0 million in gross proceeds pursuant to the Company’s $50 million at-the-market (“ATM”) program established on [...]

Information on the Total Number of Voting Rights and Shares

Information on the Total Number of Voting Rights and Shares

Mont-Saint-Guibert (Belgium), March 31 (Korea Bizwire) – In accordance with article 15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.  Share capital: EUR 4,859,382.45   Total number of securities carrying voting rights: 28,286,985 (all ordinary shares)   Total number of voting rights (= denominator): 28,286,985 (all [...]

Nyxoah Raises $3 Million from an At-the-Market Equity Offering

Nyxoah Raises $3 Million from an At-the-Market Equity Offering

Mont-Saint-Guibert, Belgium, March 27 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company raised $2.8 million in gross proceeds pursuant to the Company’s $50 million at-the-market (“ATM”) program established on [...]

Nyxoah Announces a $15 Million Private Placement Financing

Nyxoah Announces a $15 Million Private Placement Financing

Mont-Saint-Guibert, Belgium, March 23 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced a €13.35 million private placement financing from the sale of 2,047,544 new ordinary shares at a price per share of [...]

Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

Nyxoah Reports Fourth Quarter and Full Year 2022 Financial and Operating Results

Mont-Saint-Guibert, Belgium, March 22 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the fourth quarter and full year 2022. Recent Financial and Operating Highlights Completed all 115 implants in the [...]

Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023

Nyxoah to Release Fourth Quarter and Full Year 2022 Financial Results on March 22, 2023

Mont-Saint-Guibert, Belgium, March 8 (Korea Bizwire) – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will release financial results for the fourth quarter and full year 2022 on Wednesday, March 22, [...]